Akebia Therapeutics Ownership | Who Owns Akebia Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Akebia Therapeutics Ownership Summary

Akebia Therapeutics is owned by 27.44% institutional investors, 2.09% insiders, and 70.47% retail investors. Blackrock is the largest institutional shareholder, holding 5.68% of AKBA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.81% of its assets in Akebia Therapeutics shares.

AKBA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Akebia Therapeutics	27.44%	2.09%	70.47%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	11.64M	5.68%	$11.87M
Vanguard group	9.28M	4.53%	$9.46M
Alerce investment management	5.75M	2.80%	$5.86M
Geode capital management	4.54M	2.21%	$4.63M
Renaissance	3.91M	1.91%	$3.99M
State street	2.75M	1.34%	$2.80M
Jacobs levy equity management	2.09M	1.02%	$2.14M
Qube research	1.74M	0.85%	$1.78M
Connor, clark & lunn investment management	1.05M	0.51%	$1.07M
Federated hermes	865.25K	0.42%	$882.56K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alerce investment management	5.75M	11.49%	$5.86M
Orchard capital management	86.83K	0.03%	$88.56K
Wealth effects	27.00K	0.01%	$27.54K
Eagle wealth strategies	12.00K	0.01%	$12.24K
Jacobs levy equity management	2.09M	0.01%	$2.14M
State of wyoming	49.73K	0.01%	$50.72K
Cedrus	13.70K	0.01%	$13.97K
Renaissance	3.91M	0.01%	$3.99M
Compass ion advisors	25.09K	0.01%	$45.92K
Virtu financial	75.08K	0.01%	$77.00K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	11.64M	0.00%	9.10M
Geode capital management	4.54M	0.00%	2.72M
State street	2.75M	0.00%	2.10M
Vanguard group	9.28M	0.00%	1.05M
Bank of new york mellon	604.55K	0.00%	585.79K

Top Sellers

Holder	Shares	% Assets	Change
Alerce investment management	5.75M	11.49%	-7.46M
Acadian asset management	-	-	-4.06M
Millennium management	45.69K	-	-3.22M
Goldman sachs group	348.92K	0.00%	-1.06M
Qube research	1.74M	0.00%	-518.06K

New Positions

Holder	Shares	% Assets	Change	Value
Nuveen asset management	380.54K	0.00%	380.54K	$388.15K
Corebridge financial	111.91K	0.00%	111.91K	$115.27K
New york state common retirement fund	101.10K	0.00%	101.10K	$103.00K
Alliancebernstein	77.64K	-	77.64K	$79.19K
Voya investment management	71.70K	0.00%	71.70K	$73.13K

Sold Out

Holder	Change
Hexagon capital partners	-186.00
Headlands	-208.00
Laurel wealth advisors	-229.00
Redwood wealth management group	-300.00
Capital advisors	-320.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	108	-14.29%	56,234,084	-1.41%	27	3.04%	53	-27.40%	24	-
Mar 31, 2024	126	38.46%	57,038,634	4.20%	30	3.55%	73	97.30%	24	14.29%
Dec 31, 2023	91	13.75%	54,737,421	7.65%	29	3.92%	37	32.14%	21	-
Sep 30, 2023	80	-3.61%	50,849,494	1.12%	27	3.67%	28	-6.67%	21	-4.55%
Jun 30, 2023	83	18.57%	50,284,843	-3.26%	27	3.44%	30	7.14%	22	57.14%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	5.95M	2.81%	-
iShares Russell 2000 ETF	5.53M	2.63%	-12.43K
Vanguard Institutional Extnd Mkt Idx Tr	2.60M	1.24%	-
Fidelity Small Cap Index	2.13M	1.01%	-40.14K
iShares Russell 2000 Value ETF	1.78M	0.84%	-
Fidelity Extended Market Index	1.12M	0.53%	23.02K
Vanguard Russell 2000 ETF	948.40K	0.45%	-5.92K
State St Russell Sm/Mid Cp® Indx NL Cl C	850.51K	0.40%	-42.80K
Federated Hermes MDT Small Cap Growth IS	809.71K	0.39%	-
Federated Hermes MDT SCG Institutional	809.71K	0.39%	-1.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 13, 2024	Hadas Nicole R.	SVP, Chief Legal Officer	Sell	$15.14K
May 13, 2024	Dahan Michel	SVP, Chief Operating Officer	Sell	$43.90K
Aug 25, 2023	Burke Steven Keith	SVP, Chief Medical Officer	Sell	$31.05K
Feb 29, 2024	Dahan Michel	SVP, Chief Operating Officer	Sell	$13.68K
Feb 29, 2024	Hadas Nicole R.	SVP, Chief Legal Officer	Sell	$9.44K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	2
2024 Q1	-	10
2023 Q3	-	1
2023 Q2	-	4
2023 Q1	-	19

AKBA Ownership FAQ

Who Owns Akebia Therapeutics?

Akebia Therapeutics shareholders are primarily institutional investors at 27.44%, followed by 2.09% insiders and 70.47% retail investors. The average institutional ownership in Akebia Therapeutics's industry, Biotech Stocks , is 44.97%, which Akebia Therapeutics falls below.

Who owns the most shares of Akebia Therapeutics?

Akebia Therapeutics’s largest shareholders are Blackrock (11.64M shares, 5.68%), Vanguard group (9.28M shares, 4.53%), and Alerce investment management (5.75M shares, 2.80%). Together, they hold 13.01% of Akebia Therapeutics’s total shares outstanding.

Does Blackrock own Akebia Therapeutics?

Yes, BlackRock owns 5.68% of Akebia Therapeutics, totaling 11.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.87M$. In the last quarter, BlackRock increased its holdings by 9.1M shares, a 358.35% change.

Who is Akebia Therapeutics’s biggest shareholder by percentage of total assets invested?

Alerce investment management is Akebia Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.49% of its assets in 5.75M Akebia Therapeutics shares, valued at 5.86M$.

Who is the top mutual fund holder of Akebia Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Akebia Therapeutics shares, with 2.81% of its total shares outstanding invested in 5.95M Akebia Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools